Alivus Life Sciences Ltd.

NSE: ALIVUS | BSE: 543322 | ISIN: INE03Q201024 | Industry: Pharmaceuticals
| Mid-range Performer
1022.2000 19.90 (1.99%)
NSE Jul 10, 2025 15:31 PM
Volume: 59,260
 

logo
Alivus Life Sciences Ltd.
29 Apr 2023
1022.20
1.99%
buy
by BOB Capital Markets Ltd.
Target: 600
BOB Capital Markets Ltd.
Q4 revenue of Rs 6.2bn (+21% YoY) beat our estimate by 14% driven by recovery in CDMO and growth in API
 
Alivus Life Sciences Ltd. is trading below its 50 day SMA of 1054.8
More from Alivus Life Sciences Ltd.
Recommended
Market closes lower, SBI plans a Rs 25,000 crore share sale via a QIP
Trendlyne Marketwatch | 10 Jul 2025, 04:12PM
Five winners from analysts: Stocks set to start FY26 with a bang | Screener: Stocks analysts are most …
The Baseline | 10 Jul 2025, 12:14PM
Glenmark Life Sciences: The hived off API business of Glenmark Pharma goes public
| 27 Jul 2021